Thompson Davis & Co’s Humana HUM Stock Holding History

Thompson Davis & Co’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-71	Closed	-$17K	–	863
2017 Q3	$17K	Hold	71	–	–	0.03%	526
2017 Q2	$17K	Hold	71	–	–	0.03%	516
2017 Q1	$15K	Hold	71	–	–	0.02%	584
2016 Q4	$14K	Hold	71	–	–	0.02%	611
2016 Q3	$13K	Hold	71	–	–	0.02%	602
2016 Q2	$13K	Hold	71	–	–	0.02%	576
2016 Q1	$13K	Hold	71	–	–	0.02%	579
2015 Q4	$13K	Sell	71 -16	-18%	-$2.81K	0.02%	591
2015 Q3	$16K	Sell	87 -11	-11%	-$2.03K	0.02%	532
2015 Q2	$19K	Sell	98 -640	-87%	-$119K	0.02%	554
2015 Q1	$131K	Buy	738 +651	+748%	+$103K	0.16%	140
2014 Q4	$12K	Hold	87	–	–	0.01%	685
2014 Q3	$11K	Buy	+87	New	+$11.1K	0.01%	669

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Thompson Davis & Co's HUM Position: Q4 2017 in Review

Thompson Davis & Co sold out of Humana (HUM) in Q4 2017, closing a stake of 71 shares — an estimated $17K sold.

Thompson Davis & Co first reported a position in HUM in Q3 2014 and held it in 13 quarters. The position peaked at $131K in Q1 2015. 691 funds tracked by Wall St. Rank hold HUM as of Q4 2017.

Thompson Davis & Co reported no remaining Humana position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 71 Humana shares in Q4 2017, an estimated $17K.
Thompson Davis & Co first reported a position in Humana in Q3 2014 and held it in 13 quarters.
Thompson Davis & Co's Humana position peaked at $131K in Q1 2015.
691 funds tracked by Wall St. Rank held Humana as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.